Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-27T19:58:44.445Z Has data issue: false hasContentIssue false
  • English
  • Français

Kawasaki disease complicated by cerebral infarction

Published online by Cambridge University Press:  18 April 2005

Kenji Suda ,
Masahiko Matsumura  and
Shigeru Ohta
Kenji Suda
Affiliation:
Department of Pediatrics, Tenri Hospital, Tenri City, Japan
Masahiko Matsumura
Affiliation:
Department of Pediatrics, Tenri Hospital, Tenri City, Japan
Shigeru Ohta
Affiliation:
Department of Pediatrics, Tenri Hospital, Tenri City, Japan
Get access Rights & Permissions [Opens in a new window]

Abstract

An 8-month-old boy presented with right hemiplegia of sudden onset after 20 days of Kawasaki disease, which was not initially treated by gamma globulin. Cranial X-ray computed tomography confirmed cerebral infarction as the cause of the right hemiplegia. In subsequent weeks, he developed multiple thromboses in coronary aneurysms. He successfully underwent intracoronary thrombolysis using tissue plasminogen activator without haemorrhagic complications. Cerebral infarction as a complication of Kawasaki disease is rare, and is a difficult clinical situation to manage.

Keywords

Coronary aneurysmcoronary thrombosisintracoronary thrombolysis
Type
Brief Report
Information
Cardiology in the Young , Volume 13 , Issue 1 , February 2003 , pp. 103 - 105
Copyright
© 2003 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Newburger JW. Kawasaki Disease. Curr Treat Options Cardiovasc Med 2000; 2: 227–236.Google Scholar
Terasawa K, Ichinose E, Matsusaki T, Kato H. Neurological complication in Kawasaki disease. Brain Dev 1983; 5: 371–437.Google Scholar
Fujiwara S, Yamano T, Hattori M, Fujiseki Y, Shimada M. Asymptomatic cerebral infarction in Kawasaki disease. Pediatr Neurol 1992; 8: 235–236.Google Scholar
Lapointe JS, Nugent RA, Graeb DA, Robertson WD. Cererbral infarction and regression of widespread aneurysms in Kawasaki's disease: case report. Pediatr Radiol 1984; 14: 1–5.Google Scholar
Gurwitz JH, Gore JM, Goldberg RJ, et al. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2. Ann Intern Med 1998; 129: 597–604.Google Scholar
Tsubata S, Ichida F, Hamamichi Y, Miyazaki A, Hashimoto I, Okada T. Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease. Pediatr Cardiol 1995; 16: 186–189.Google Scholar
Chandwaney RH, Stathopoulos T, Sunew J, McPherson D, Davidson CJ. Adjunctive therapies in the cath lab. Successful thrombolysis using the combination of tissue plasminogen activator and abciximab in an adult with Kawasaki's disease. J Invasive Cardiol 2001; 13: 651–653.Google Scholar